FANDOM


"Justin Claybourne owns Claybourne Pharmaceuticals that recently acquired the rights to this drug Dycloseral, which fights this particular strain of TB."
—Oliver Queen[src]

Claybourne Pharmaceuticals was a pharmaceutical company led by Justin Claybourne. When AK Desmond Group produced the bioweapon-like weaponized tuberculosis, Claybourne Pharm immediately increased the prices of the drug Dycloseral that could cure it. The company shut down after the CEO was killed by the Hood.[1]

History

Dycloserol

The company's website.

After AK Desmond Group caused a massive outbreak of weaponized tuberculosis in Lamb Valley, Claybourne Pharmaceuticals immediately increased the price of the Dycloseral drug that they recently acquired rights to, from $10 a pill to $1,000 overnight, making it impossible for the poor people to get their hands on the cure. This caused the Hood to suspect Justin Claybourne as the man behind the crisis, and his suspicions proven correct. After Claybourne refused to correct his misdeeds, the Hood hunted him down at AK Desmond hideout and killed Claybourne, along with most of his guards. After their CEO's death, the company shut down.[1]

Prometheus later made a hideout in an old manufacturing plant of Claybourne Pharmaceuticals. He managed to re-activate the production of the Dycloseral drug, with the manufacturing plant reporting heavy usage of water and power over the last few months before December, 2016. Team Arrow tracked him down and fought Prometheus at this hideout, with Oliver Queen suspecting him to be Justin Claybourne himself. After Evelyn Sharp's betrayal and Prometheus's escape, the vigilantes left the plant. It was later investigated by Billy Malone, who located a baby photo at the company's CEO's office, causing Team Arrow to suspect Prometheus to be Claybourne's child. The Throwing Star Killer refused to confirm anything, abducting Billy and using him as bait for Oliver Queen at AK Desmond Group's old hideout.[1]

Appearances

Arrow

Season 5

References

  1. 1.0 1.1 1.2 "What We Leave Behind"